VIVUS, Inc. (VVUS)
A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.
Recs
IBDvalueinvestin
(96.41)
Submitted: 11/18/2009 11:55:19 AM :
Start Price:
$9.02
VVUS Score:
-6.33
Use only 5% of your portfolio to by shares of companies that have buyout potential.
Recs
sk8terman
(74.10)
Submitted: 11/16/2009 3:07:44 PM :
Start Price:
$7.91
VVUS Score:
+6.53
This and OREX have the strongest weight loss drugs in stage III. Bought both.
Recs
mrjconstantine
(< 20)
Submitted: 11/7/2009 6:26:30 AM :
Start Price:
$7.49
VVUS Score:
+9.64
With the Takeda/Amylin partnership Vivus can't, or shouldn't, be far behind. Daily oral, VVUS' Qnexa, vs. Amylin's injectable, shouldn't even be a contest. Include data that could be therapeutic for Type 2 diabetes and it's a knockout. Looking for partner or buyout within the next 6-12 months if not sooner. Great time to accumulate this affordable, still risky and speculative mind you, before positive news doubles the current price.
Recs
cashsage
(77.50)
Submitted: 11/5/2009 4:29:53 AM :
Start Price:
$7.24
VVUS Score:
-11.30
VVUS has a too high valuation compared to its sales potential. It is also loss making at least until 2011.
Recs
earthunit
(56.90)
Submitted: 11/2/2009 7:12:55 PM :
Start Price:
$7.39
VVUS Score:
+6.98
Blockbuster obesity drug in the making. WILL get FDA approval in 2010.
Recs
Recs
sanjaymathew
(98.50)
Submitted: 9/11/2009 1:02:20 PM :
Start Price:
$10.99
VVUS Score:
-30.05
Stock is down 7% today. Good time to add to Caps. should more than double from here. Very impressive results for Qnexa.
Recs
msftgev
(96.87)
Submitted: 9/9/2009 9:11:04 PM :
Start Price:
$12.05
VVUS Score:
-37.69
Just want to see if their diet pill gets fda approval.
In real life I avoid Health and pharma stocks like the plague.
Recs
englandstumpy
(30.42)
Submitted: 9/9/2009 12:17:04 PM :
Start Price:
$11.65
VVUS Score:
-35.22
Drugs for obesity and sexual dysfunction.Any success a winner.
Recs
HooliganJ
(99.18)
Submitted: 9/9/2009 11:15:28 AM :
Start Price:
$11.78
VVUS Score:
+36.37
The Phentermine and Topiramate cocktail might not pan out to be a miracle drug.
Recs
Iluvitar
(91.01)
Submitted: 7/27/2009 3:36:30 PM :
Start Price:
$7.09
VVUS Score:
+4.59
Long shot but new drugs could blow this through the roof!
Recs
ebitdat
(65.42)
Submitted: 7/24/2009 4:08:27 PM :
Start Price:
$7.49
VVUS Score:
-1.51
Best weight-loss drug in the field and looks good for diabetes, too. Terrific balance sheet, phase III pipeline, and more-than competent management makes it a good play even in relatively lean times.
Recs
Defshark82
(78.92)
Submitted: 7/23/2009 7:45:33 PM :
Start Price:
$7.20
VVUS Score:
+2.23
I think the potential of their weight loss drug could be huge. I like other drugs in their pipeline as well.
Recs
ocdgirl2000
(< 20)
Submitted: 6/24/2009 7:12:34 AM :
Start Price:
$5.38
VVUS Score:
+32.93
This company is going to take on the entire weight loss industry, in addition to the entire junk food industry. Watch out Mars, M&M, and all the other candy manufacturers. No one will care any more.
Recs
oldtimer52534
(< 20)
Submitted: 6/23/2009 5:45:35 PM :
Start Price:
$5.38
VVUS Score:
+32.93
When VVUS Phase 3 tests are complete and they get a good partner the stock will be off and running. I like it so much I added the stock to my portfolio
Recs
xpanshun
(< 20)
Submitted: 5/20/2009 5:57:53 AM :
Start Price:
$4.23
VVUS Score:
+77.36
Phase 3 results will be successfull for Qnexa, and they also have impotence drug due for results.
Recs
hwyman64
(97.44)
Submitted: 3/20/2009 4:20:09 PM :
Start Price:
$4.39
VVUS Score:
+49.55
New "diet pills"....playing Wi and popping pills is easier than walking the dog!!!!!!
Recs
bigsmitty52
(98.41)
Submitted: 3/20/2009 1:32:16 PM :
Start Price:
$4.26
VVUS Score:
+52.64
See comment on ARNA
Recs
RJCinMA
(< 20)
Submitted: 2/21/2009 4:45:43 PM :
Start Price:
$4.52
VVUS Score:
+42.12
This stock is very cheap at current levels. The company is in the same or better shape financially now at $4.50, then it was at $9.00. Too many positive results from their trials on drugs in the pipeline for the price for this company to stay at these levels. I believe the stock will be back to nine dollars or more within a year.
Recs
pick1998
(75.56)
Submitted: 1/25/2009 2:45:15 AM :
Start Price:
$4.22
VVUS Score:
+64.64
VVUS seems to be a leader in three-way race for a obesity drug after OREX released mixed data before JP Morgan confab in Jan, 09. ARNA is far behind.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 45 1 2 3 Next »